Article
Andrographolide induces degradation of mutant p53 via activation of Hsp70.
International journal of oncology - 1 Aug 2018
Sato Hirofumi, Hiraki Masatsugu, Namba Takushi, Egawa Noriyuki, Baba Koichi, Tanaka Tomokazu, Noshiro Hirokazu
Abstract excerpt
The tumor suppressor gene p53 encodes a transcription factor that regulates various cellular functions, including DNA repair, apoptosis and cell cycle progression. Approximately half of all human cancers carry mutations in p53 that lead to loss of tumor suppressor function or gain of functions that promote the cancer phenotype. Thus, targeting mutant p53 as an anticancer therapy has attracted considerable...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
